Insights from 2024 SGO Annual Meeting

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Insights from 2024 SGO Annual Meeting

Videos

Playback speed

10 seconds

SGO 2024 Insights: "RUBY Part 1 & Part 2 Trial - Dostarlimab + Chemo for Primary Advanced/Recurrent Endometrial Cancer & PARPi Maintenance in Patients Receiving Dostarlimab + Chemo"

By Insights from 2024 SGO Annual Meeting FEATURING Mansoor Raza Mirza

419 views

April 9, 2024

Comments 0

The Role Of Folate Receptor Alpha In Ovarian Cancer

Feat. D. M. O'Malley

The Importance of HRD Testing in Advanced Ovarian Cancer

Feat. M. Markman

Videos

SGO 2024 Endometrial Cancer Highlights

Insights from 2024 SGO Annual Meeting

P. Binder

292 views

SGO 2024 Insights: "COMB1NE Study - Characteristics and Real-World O…

Insights from 2024 SGO Annual Meeting

P. Thaker

182 views

SGO 2024 Summary: "Key Updates in Endometrial Cancer"

Insights from 2024 SGO Annual Meeting

M. Raza Mirza

509 views

SGO 2024 Insights: "innovaTV 301/ENGOT-cx12/GOG-3057 Study - Efficac…

Insights from 2024 SGO Annual Meeting

B. Slomovitz

312 views

SGO 2024 Insights: "Platinum-Free Interval & Response to Platinum Re…

Insights from 2024 SGO Annual Meeting

P. Haight

216 views

SGO 2024 Insights: "Patterns in Maintenance Therapy Use in Advanced …

Insights from 2024 SGO Annual Meeting

S. Taylor

143 views

SGO 2024 Insights: "Implementation of IO in Recurrent Endometrial Ca…

Insights from 2024 SGO Annual Meeting

A. Smith

155 views

SGO 2024 Insights: "RUBY Part 1 & Part 2 Trial - Dostarlimab + Chemo…

Insights from 2024 SGO Annual Meeting

M. Raza Mirza

419 views

SGO 2024 Insights: "Use of ChatGPT for Management Recommendations in…

Insights from 2024 SGO Annual Meeting

L. Finch

172 views

SGO 2024 Insights: "AI-Powered Insights - Assessment of ChatGPT's Tr…

Insights from 2024 SGO Annual Meeting

E. Rios-Doria

87 views

SGO 2024 Insights: "Impact of Maintenance Bevacizumab Following Chem…

Insights from 2024 SGO Annual Meeting

M. Kuznicki

314 views

SGO 2024 Insights: "GOG-0258 - OS by Molecular Classification With a…

Insights from 2024 SGO Annual Meeting

A. Clements

502 views

SGO 2024 Insights: "The Use of Rucaparib vs. Placebo Maintenance The…

Insights from 2024 SGO Annual Meeting

B. Corr

287 views

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective Gluco…

Insights from 2024 SGO Annual Meeting

N. Colombo

258 views

SGO 2024 Insights: "Non-Radical Surgical Therapy for Early Stage Cer…

Insights from 2024 SGO Annual Meeting

A. Covens

104 views